Updates
** Medical device maker Becton Dickinson's BDX.N shares fall 3.7% to $169.89, its lowest in over eight years
** Co's quarterly revenue of $5.89 billion misses analysts' average expectation of $5.90 billion - data compiled by LSEG
** Reports Q4 adj. profit of $3.96/shr vs estimates of $3.92/shr
** BDX now expects 2026 adjusted profit between $14.75 and $15.05/shr, compared with estimates of $14.84/shr
** "Shares are trading lower due to an underwhelming 2026 outlook and ongoing pressures in its core business," says RBC Capital Markets analyst Shagun Singh
** Including the session's move, stock down ~25% YTD
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))